Press releases, leadership announcements, and coverage of our mission to bring effective medicine to the brain. For media inquiries, reach us at press@lotusneuro.com.
Press Release
September 9, 2026
The clinical-stage biotech unveils a modality-agnostic platform and partnership-first model pairing focused ultrasound with medicines for brain cancer, neurodegeneration and other focal neurologic disease, with roughly 600 treatment sessions of clinical experience behind it.
Press Release
June 15, 2026
The veteran neurologist and drug developer — formerly of Codiak BioSciences, Biogen, and United Neuroscience — joins as Founding Scientist to shape scientific and clinical strategy across the company's neuro-oncology pipeline.
Press Release
December 17, 2025
Insightec spins out and launches Lotus Neuro, a clinical-stage biotech advancing brain-targeted therapeutics through precision, low-frequency focused ultrasound — led by CEO Arjun (JJ) Desai, MD, and funded by Nexus NeuroTech Ventures.
Ajay Verma MD PhD and members of the clinical development team will attend CNS Summit, the annual convening of clinical operations, CRO, and translational leadership across central nervous system drug development.
Hosted by the Dutch Neuro Focused Ultrasound Consortium at the Princess Máxima Center for Pediatric Oncology, bringing together the European academic focused-ultrasound community, including groups working on diffuse midline glioma.
The Focused Ultrasound Foundation's field-wide meeting, with sessions spanning ALS, Alzheimer's disease, glioblastoma, diffuse midline glioma, and Parkinson's disease. Ajay Verma MD PhD and Ahmed Mohyeldin MD PhD will attend.
Founding Scientist Ajay Verma MD PhD will lead the pre-conference workshop comparing focal blood-brain barrier opening with systemic transferrin-receptor shuttles: the clinical evidence and safety data behind each, the capital, procedural, and manufacturing economics of each route, and the combination strategies that could reach deep brain structures neither approach reaches alone.
